Search
-
-
The Dana Pe'er Lab
… Job Title Postdoctoral Researcher Education PhD, Carnegie Mellon University (Computational Biology); MS, Carnegie Mellon University (Machine Learning); MS, Tsinghua University (Control Science and Engineering); BEng, Tsinghua University (Automation) Degree PhD Email [email protected]
-
COVID-19 Information for Patients and Caregivers
MSK Infectious disease specialist Tobias Hohl answers questions cancer patients may have about tests for COVID-19 antibodies.
… Tests for COVID-19 antibodies are beginning to play a role in determining who has had the infection as well as calculating the prevalence of the disease. We asked Tobias Hohl , Chief of Memorial Sloan Kettering’s Infectious Diseases and Allergy Service, to explain what these tests mean for people with
-
COVID-19 Information for Patients and Caregivers
El especialista en enfermedades infecciosas de MSK, Tobias Hohl, responde a las preguntas que los pacientes con cáncer puedan tener sobre las pruebas de anticuerpos contra la COVID-19.
… Las pruebas de anticuerpos contra la COVID-19 están empezando a desempeñar un papel tanto para determinar quién ha tenido la infección como para calcular la prevalencia de la enfermedad. Le pedimos a Tobias Hohl , jefe del Servicio de Enfermedades Infecciosas de Memorial Sloan Kettering, que explique
-
COVID-19 Information for Patients and Caregivers
Специалист MSK по инфекционным заболеваниям Тобиас Холь отвечает на вопросы, которые могут возникнуть у больных раком о тестах на антитела к COVID-19.
… Тесты на антитела к COVID-19 начинают играть важную роль в выявлении людей, перенесших инфекцию, а также в оценке распространения заболевания. Мы попросили Тобиаса Холя, главу инфекционного отделения Memorial Sloan Kettering , объяснить, что эти тесты значат для больных раком и для общества в целом.
-
News
In our recently published review paper we provide a comprehensive update on the cardiotoxicities associated with contemporary breast cancer treatment and the latest strategies for their prevention, detection, and management.
… Friday, June 28, 2019 It is critical to balance the expected benefits of cancer treatment with cardiovascular risk and identify strategies to prevent cardiotoxicity and improve outcomes and the long-term quality of life for breast cancer survivors. In our review paper published recently in the journal
-
Pediatric Hematologist-OncologistMemorial Sloan Kettering pediatric oncologist Nai-Kong Cheung specializes in immunologic approaches for the diagnosis and treatment of pediatric cancers. His main focus is the treatment of neuroblastoma, a tumor that arises from primitive cells of the sympathetic nervous system which primarily affects young children.
… Pediatric Hematologist-Oncologist Job Title Enid A. Haupt Chair in Pediatric Oncology I am a pediatric oncologist at MSK Kids who specializes in immunologic approaches to diagnose and treat pediatric cancers. My main focus is the treatment of neuroblastoma, a tumor arising from primitive cells of the
-
Pediatric Hematologist-OncologistNai-Kong Cheung es oncóloga pediátrica del Memorial Sloan Kettering, especializada en técnicas inmunológicas para el diagnóstico y tratamiento contra el cáncer pediátrico. Su principal objetivo es el tratamiento del neuroblastoma, un tumor que nace en las células primitivas del sistema nervioso simpático que afecta de manera específica a niños.
… Pediatric Hematologist-Oncologist Job Title Cátedra Enid A. Haupt de oncología pediátrica Soy oncólogo pediátrico de MSK Kids, especializada en técnicas inmunológicas para diagnosticar y tratar el cáncer en niños. Mi principal objetivo es el tratamiento del neuroblastoma, un tumor que nace en las células
-
The Joseph Sun Lab
… Job Title Research Fellow; Current Position: Lecturer, Imperial College London Email [email protected] Office Phone 646-888-3237
-
The Danwei Huangfu Lab
… Job Title Graduate Research Assistant Samuel Kaplan graduated from Northeastern University with a degree in Biochemistry. Following a co-op at Rubius Therapeutics, he joined the manufacturing group of the organization for the next two years. He worked on erythrocyte differentiation protocol development